Ascension Medicines provides in-home therapy with monoclonal antibodies to patients who have been diagnosed with or exposed to SARS-CoV-2 (COVID-19) in accordance with the Food and Drug Administration's (FDA's) Emergency Use Authorization (EUA). The COVID-19 pandemic has illuminated many health disparities within our communities. Our goal at Ascension Medicines is to meet patients where they are and decrease pre-existing barriers to treatment.